Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pediatric dosing considerations in ophthalmology.

T F Patton, J R Robinson

    Journal of Pediatric Ophthalmology
    |May 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Test-retest reliability of the two-point discrimination test on the sole of the foot in people with multiple sclerosis.

    Physiological measurement·2020
    Same author

    The Avon patellofemoral joint arthroplasty: two- to 18-year results of a large single-centre cohort.

    The bone & joint journal·2018
    Same author

    Survivorship and clinical outcome of the minimally invasive Uniglide medial fixed bearing, all-polyethylene tibia, unicompartmental knee arthroplasty at a mean follow-up of 7.3years.

    The Knee·2016
    Same author

    Dropped Gallstones Causing a Perihepatic Abscess and Empyema.

    Case reports in surgery·2015
    Same author

    Bristol index of patellar width to thickness (BIPWiT): a reproducible measure of patellar thickness from adult MRI.

    The Knee·2014
    Same author

    Do long leg supine CT scanograms correlate with weight-bearing full-length radiographs to measure lower limb coronal alignment?

    The Knee·2013

    Pediatric ophthalmic drug dosing requires careful consideration to avoid toxicity. Reducing doses for infants and children may be possible without losing therapeutic benefits, prioritizing safety.

    Area of Science:

    • Ophthalmology
    • Pediatric Pharmacology
    • Drug Safety

    Background:

    • Topical ophthalmic drug administration often uses adult dosages for pediatric patients.
    • This practice, while achieving therapeutic effects, poses risks of significant short- and long-term toxicity in children.

    Purpose of the Study:

    • To evaluate the potential for dose reduction of topical ophthalmic drugs in pediatric populations.
    • To highlight the critical need to address toxicity concerns in infants and neonates.

    Main Methods:

    • Review of existing data and pharmacokinetic principles.
    • Consideration of body weight and total body surface area for dose calculation.
    • Analysis of systemic absorption of topically applied ophthalmic medications.

    Related Experiment Videos

    Main Results:

    • Dose reduction may be feasible for infants and children up to three years old.
    • Systemic absorption can exceed 90% in neonates, increasing toxicity risk.
    • Total body surface area is a relevant metric for determining safe pediatric doses.

    Conclusions:

    • Pediatric ophthalmic drug dosing must account for age-specific factors, particularly low body weight.
    • Prioritizing toxicity reduction may necessitate lower doses or alternative medications for potent drugs.
    • Ensuring infant and neonate safety is paramount in ophthalmic drug therapy.